Oui, l'usage de drogues peut mener à des comportements sexuels à risque, augmentant le risque d'IST.
DroguesFacteurs de risque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vénéréologie : Questions médicales les plus fréquentes",
"headline": "Vénéréologie : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vénéréologie : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-14",
"dateModified": "2026-08-02",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vénéréologie"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Médecine",
"url": "https://questionsmedicales.fr/mesh/D008511",
"about": {
"@type": "MedicalCondition",
"name": "Médecine",
"code": {
"@type": "MedicalCode",
"code": "D008511",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "H02.403"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Vénéréologie",
"alternateName": "Venereology",
"code": {
"@type": "MedicalCode",
"code": "D014686",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "P V Chernyshov",
"url": "https://questionsmedicales.fr/author/P%20V%20Chernyshov",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology and Venereology, National Medical University, Kiev, Ukraine."
}
},
{
"@type": "Person",
"name": "A Y Finlay",
"url": "https://questionsmedicales.fr/author/A%20Y%20Finlay",
"affiliation": {
"@type": "Organization",
"name": "Division of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, UK."
}
},
{
"@type": "Person",
"name": "L Manolache",
"url": "https://questionsmedicales.fr/author/L%20Manolache",
"affiliation": {
"@type": "Organization",
"name": "Dermatology, Dali Medical, Bucharest, Romania."
}
},
{
"@type": "Person",
"name": "A Svensson",
"url": "https://questionsmedicales.fr/author/A%20Svensson",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology and Venereology, Skane University Hospital, Malmö, Sweden."
}
},
{
"@type": "Person",
"name": "A Bewley",
"url": "https://questionsmedicales.fr/author/A%20Bewley",
"affiliation": {
"@type": "Organization",
"name": "Whipps Cross University Hospital, London, UK."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The Tiber Island in the history of Dermatology and Venereology including the curious history of \"K syndrome\", the fictitious disease that scared the Nazis.",
"datePublished": "2024-09-11",
"url": "https://questionsmedicales.fr/article/39270810",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.clindermatol.2024.09.018"
}
},
{
"@type": "ScholarlyArticle",
"name": "S2k guidelines on diagnosis and treatment of linear IgA dermatosis initiated by the European Academy of Dermatology and Venereology.",
"datePublished": "2024-02-29",
"url": "https://questionsmedicales.fr/article/38421060",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/jdv.19880"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ten Years of HIV Diagnosis in a Dermatology and Venereology Department: A Retrospective Study on Demographic, Clinical, and Laboratory Characteristics.",
"datePublished": "2024-04-20",
"url": "https://questionsmedicales.fr/article/38648929",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ad.2024.04.016"
}
},
{
"@type": "ScholarlyArticle",
"name": "[[Translated article]]Recommendations from the Spanish Academy of Dermatology and Venereology Psoriasis Working Group on the Management of Patients with Cancer and Psoriasis.",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38821353",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ad.2024.05.011"
}
},
{
"@type": "ScholarlyArticle",
"name": "Ten years of HIV diagnosis in a Dermatology and Venereology Department: a retrospective study on demographic, clinical, and laboratory characteristics.",
"datePublished": "2024-02-02",
"url": "https://questionsmedicales.fr/article/38311223",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ad.2023.09.024"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Professions de santé",
"item": "https://questionsmedicales.fr/mesh/D006281"
},
{
"@type": "ListItem",
"position": 3,
"name": "Médecine",
"item": "https://questionsmedicales.fr/mesh/D008511"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vénéréologie",
"item": "https://questionsmedicales.fr/mesh/D014686"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vénéréologie - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vénéréologie",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-09-01",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vénéréologie",
"description": "Comment diagnostiquer une IST ?\nQuels tests sont utilisés pour le VIH ?\nComment identifier une chlamydia ?\nQuels symptômes nécessitent un test ?\nLes tests sont-ils confidentiels ?",
"url": "https://questionsmedicales.fr/mesh/D014686#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vénéréologie",
"description": "Quels sont les symptômes de la syphilis ?\nComment se manifeste l'herpès génital ?\nQuels signes indiquent une infection à gonocoque ?\nQuels symptômes sont associés à la trichomonase ?\nLes IST peuvent-elles être asymptomatiques ?",
"url": "https://questionsmedicales.fr/mesh/D014686#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vénéréologie",
"description": "Comment prévenir les IST ?\nLe vaccin contre le HPV est-il efficace ?\nPourquoi faire des tests réguliers ?\nLes préservatifs protègent-ils contre toutes les IST ?\nQuelles sont les pratiques sexuelles sûres ?",
"url": "https://questionsmedicales.fr/mesh/D014686#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vénéréologie",
"description": "Comment traite-t-on la chlamydia ?\nQuel est le traitement du VIH ?\nComment soigner la syphilis ?\nQuels médicaments pour l'herpès génital ?\nY a-t-il un vaccin contre le HPV ?",
"url": "https://questionsmedicales.fr/mesh/D014686#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vénéréologie",
"description": "Quelles complications peuvent survenir avec la syphilis ?\nQuels risques le VIH pose-t-il ?\nQuelles complications de l'herpès génital ?\nComment la gonorrhée peut-elle affecter la santé ?\nLes IST peuvent-elles causer des cancers ?",
"url": "https://questionsmedicales.fr/mesh/D014686#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vénéréologie",
"description": "Quels sont les principaux facteurs de risque des IST ?\nL'âge influence-t-il le risque d'IST ?\nLe sexe non protégé augmente-t-il le risque ?\nLes antécédents d'IST augmentent-ils le risque ?\nLes drogues influencent-elles le risque d'IST ?",
"url": "https://questionsmedicales.fr/mesh/D014686#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une IST ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, urinaires et des prélèvements locaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le VIH ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de dépistage incluent les tests ELISA et les tests rapides d'anticorps."
}
},
{
"@type": "Question",
"name": "Comment identifier une chlamydia ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un prélèvement urinaire ou un écouvillon vaginal peut confirmer l'infection."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent un test ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs, des écoulements ou des démangeaisons génitales doivent être évalués."
}
},
{
"@type": "Question",
"name": "Les tests sont-ils confidentiels ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests IST sont généralement confidentiels et protégés par la loi."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes de la syphilis ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des ulcères, des éruptions cutanées et des ganglions enflés."
}
},
{
"@type": "Question",
"name": "Comment se manifeste l'herpès génital ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'herpès génital se manifeste par des vésicules douloureuses sur les organes génitaux."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection à gonocoque ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs lors de la miction et des écoulements purulents sont fréquents."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à la trichomonase ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des démangeaisons, des écoulements vaginaux et des douleurs."
}
},
{
"@type": "Question",
"name": "Les IST peuvent-elles être asymptomatiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines IST peuvent ne présenter aucun symptôme, rendant le dépistage crucial."
}
},
{
"@type": "Question",
"name": "Comment prévenir les IST ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'utilisation de préservatifs et le dépistage régulier sont essentiels pour la prévention."
}
},
{
"@type": "Question",
"name": "Le vaccin contre le HPV est-il efficace ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il réduit considérablement le risque d'infections et de cancers liés au HPV."
}
},
{
"@type": "Question",
"name": "Pourquoi faire des tests réguliers ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests réguliers permettent de détecter les IST asymptomatiques et de traiter rapidement."
}
},
{
"@type": "Question",
"name": "Les préservatifs protègent-ils contre toutes les IST ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les préservatifs réduisent le risque, mais ne protègent pas complètement contre toutes les IST."
}
},
{
"@type": "Question",
"name": "Quelles sont les pratiques sexuelles sûres ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pratiques sexuelles sûres incluent l'utilisation de préservatifs et la limitation des partenaires."
}
},
{
"@type": "Question",
"name": "Comment traite-t-on la chlamydia ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chlamydia est traitée par des antibiotiques comme l'azithromycine ou la doxycycline."
}
},
{
"@type": "Question",
"name": "Quel est le traitement du VIH ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH est traité par des antirétroviraux qui contrôlent la charge virale."
}
},
{
"@type": "Question",
"name": "Comment soigner la syphilis ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La syphilis est traitée efficacement avec des injections de pénicilline."
}
},
{
"@type": "Question",
"name": "Quels médicaments pour l'herpès génital ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux comme l'aciclovir aident à réduire les symptômes et les poussées."
}
},
{
"@type": "Question",
"name": "Y a-t-il un vaccin contre le HPV ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vaccin contre le HPV prévient certaines infections et cancers associés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la syphilis ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Sans traitement, la syphilis peut entraîner des problèmes cardiaques et neurologiques."
}
},
{
"@type": "Question",
"name": "Quels risques le VIH pose-t-il ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le VIH peut évoluer vers le SIDA, entraînant des infections opportunistes graves."
}
},
{
"@type": "Question",
"name": "Quelles complications de l'herpès génital ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'herpès peut causer des infections récurrentes et des complications lors de l'accouchement."
}
},
{
"@type": "Question",
"name": "Comment la gonorrhée peut-elle affecter la santé ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gonorrhée non traitée peut entraîner des complications comme l'infertilité et des douleurs pelviennes."
}
},
{
"@type": "Question",
"name": "Les IST peuvent-elles causer des cancers ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines IST, comme le HPV, sont liées à un risque accru de cancers génitaux."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque des IST ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le nombre élevé de partenaires sexuels et l'absence de protection."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'IST ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes adultes et adolescents sont plus à risque d'IST en raison de comportements sexuels."
}
},
{
"@type": "Question",
"name": "Le sexe non protégé augmente-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le sexe non protégé est un facteur majeur d'augmentation du risque d'IST."
}
},
{
"@type": "Question",
"name": "Les antécédents d'IST augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, avoir des antécédents d'IST augmente le risque de nouvelles infections."
}
},
{
"@type": "Question",
"name": "Les drogues influencent-elles le risque d'IST ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'usage de drogues peut mener à des comportements sexuels à risque, augmentant le risque d'IST."
}
}
]
}
]
}
Department of Health Sciences, Section of Dermatology, AUSL Toscana Centro, Rare Diseases Unit, European Reference Network-Skin Member, University of Florence, Italy.
The Tiber Island in Rome has a rich history as a center of worship and healthcare. Its origins date back to ancient times, with the establishment of the Temple of Asclepius marking its role in healing...
Linear IgA dermatosis (LAD) is a rare subepidermal autoimmune bullous disease (AIBD) defined by predominant or exclusive immune deposits of immunoglobulin A at the basement membrane zone of skin or mu...
These guidelines were initiated by the European Academy of Dermatology and Venereology (EADV) Task Force Autoimmune Bullous Diseases (AIBD). To achieve a broad consensus for these S2k consensus-based ...
The guidelines summarizes evidence-based and expert opinion-based recommendations (S2 level) on the diagnosis and treatment of LAD....
These guidelines will support dermatologists to improve their knowledge on the diagnosis and management of LAD....
Human immunodeficiency virus (HIV) transmission remains an important health issue, with a high burden that is felt across the world. This work aims to analyze the demographic, clinical, and laboratory...
Several studies suggest that patients with psoriasis have a higher incidence of neoplasms or recurrence, especially of the skin, which could be associated with the use of therapies to treat psoriasis....
Human immunodeficiency virus (HIV) transmission remains an important health issue, with a high burden that is felt across the world. This work aims to analyze the demographic, clinical, and laboratory...
Several studies suggest that patients with psoriasis have a higher incidence of neoplasms or recurrence, especially of the skin, which could be associated with the use of therapies to treat psoriasis....
The Austrian Society for the Promotion of Sexual Medicine and Sexual Health (Österreichische Gesellschaft zur Förderung der Sexualmedizin und der Sexuellen Gesundheit [ÖGFSSG]) was founded in 2014. Th...
The incidence of melanoma is growing in Spain. The prognostic stages of patients with melanoma are determined by various biological factors, such as tumor thickness, ulceration, or the presence of reg...
REGESMEL is a prospective, multicentre cohort of consecutive patients with invasive cutaneous melanoma that includes demographics, staging, individual, and health care-related baseline data, while sto...
A total of 450 cases of invasive cutaneous melanoma from 19 participant centres were included, with a predominance of thin melanomas ≤ 1 mm thick (54.7%), mainly located on the posterior trunk (35.2%)...
The distribution of the pathological and demographic variables of melanoma cases is consistent with data from former studies. REGESMEL has already recruited patients from 15 Spanish provinces and give...
Sexually transmitted infections are communicable diseases where the pathogen is transmitted through sexual contact. The Sexually Transmitted Infections Working Group of the Spanish Academy of Dermatol...
The incidence of melanoma is growing in Spain. The prognostic stages of patients with melanoma are determined by various biological factors, such as tumor thickness, ulceration, or the presence of reg...
REGESMEL is a prospective, multicentre cohort of consecutive patients with invasive cutaneous melanoma that includes demographics, staging, individual, and health care-related baseline data, while sto...
A total of 450 cases of invasive cutaneous melanoma from 19 participant centres were included, with a predominance of thin melanomas ≤ 1 mm thick (54.7%), mainly located on the posterior trunk (35.2%)...
The distribution of the pathological and demographic variables of melanoma cases is consistent with data from former studies. REGESMEL has already recruited patients from 15 Spanish provinces and give...